mynth
← DATABASE
11/2020

GLOBAL DIAGNOSTICS acquired by MEDICA GROUP

IRELAND Health Providers / Outpatient Care / Radiology EV €10–30M

Context

Global Diagnostics Ireland, which operates around 50 clinical centers across Ireland, has been acquired by Medica Group. For Medica, this acquisition represents a diversification of its customer base and geographic activities, as well as entry into a new market: ophthalmology and retinopathy screening.

GLOBAL DIAGNOSTICS, which reported an EBITDA margin of [members only] in 2019, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, representing a discount to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Global Diagnostics Ireland functions as a high-fidelity diagnostic partnership platform, specializing in the delivery of managed radiology and teleradiology services to both public and private healthcare sectors. The organization operates a sophisticated technical infrastructure that encompasses plain film, ultrasound, CT, and MRI managed-service solutions across dozens of clinical sites. Rather than offering generic diagnostic support, the firm utilizes its specialized technical operational depth to manage high-stakes national screening initiatives, particularly for diabetic retinopathy. Its strategy is anchored in being an embedded clinical partner for the Irish Health Service Executive (HSE), utilizing a network of certified specialist radiologists to mitigate the systemic undersupply of regional diagnostic talent. The entity facilitates the transition of complex clinical imaging into a streamlined, tech-enabled reporting workflow, ensuring that critical diagnostic data is accessible and actionable for hospital teams.

Ent. Value

€10–30M

Equity Value

[members only]

Multiples

EV / Revenue

1x–3x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2019
€5–25M
€0–5M
[members only]
2018
€5–25M
€0–5M
[members only]

Similar deals in Health Providers

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
12/2020MEDIAN KLINIKENPRIORY GROUPUNITED KINGDOMClinics / Hospitals
12/2020FRESENIUSEUGIN GROUPSPAINOutpatient Care
11/2020DWS GROUPMEDIPASSITALYRadiology
11/2020ARDIANINOVIE GROUPFRANCELabs (Biology)
11/2020APHEON (EX ERGON)VIDACURAGERMANYNursing Homes
11/2020L CATTERTONALLIANCE ANIMAL HEALTHUNITED STATESVet Clinics
10/2020INFRATILQSCAN GROUPAUSTRALIARadiology
10/2020THE VISTRIA GROUP / CENTERBRIDGE PARTNERSHELP AT HOMEUNITED STATESNursing Homes
10/2020KKR / TETHYS INVEST / ARDIAN / CNP ASSURANCES / MERIEUX EQUITY PARTNERSELSANFRANCEClinics / Hospitals
09/2020EQT PARTNERSCOLISÉEFRANCENursing Homes

REFERENCES

Valuation range: EV €10–30M

Revenue range: €5–25M

EBITDA range: €0–5M

EV/Revenue range: 1x - 3x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of GLOBAL DIAGNOSTICS by MEDICA GROUP are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: medica group